EMR Net Debt / EBITDA: current value, 10-year range and year-by-year history
Cash & Leverage
Net Debt / EBITDA History
Historically priceyAbove avgAround avgBelow avgHistorically cheap
EMR Net Debt / EBITDA by year
Yearly range of EMR’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from -0.4 to 2.9, averaging 1.4.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 2.3 | 2.3 | 2.4 | 2.3 |
| 2025 | 2.5 | 2.6 | 2.9 | 2.5 |
| 2024 | 1.0 | 1.6 | 2.2 | 1.0 |
| 2023 | -0.3 | 1.1 | 2.4 | 2.4 |
| 2022 | 1.1 | 2.1 | 2.6 | 2.3 |
| 2021 | 1.1 | 1.2 | 1.5 | 1.1 |
| 2020 | 1.4 | 1.4 | 1.7 | 1.7 |
| 2019 | 1.1 | 1.2 | 1.3 | 1.2 |
| 2018 | 0.7 | 0.9 | 1.3 | 1.3 |
| 2017 | -0.4 | 0.4 | 0.7 | 0.7 |
| 2016 | -0.0 | 0.6 | 1.3 | -0.0 |
Get notified when EMR Net Debt / EBITDA crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.
Formula
(Total Debt − Cash) / EBITDAHow to read this chart
Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.
Key caveats
- Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
- Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.